NIVF Class A NewGenIvf Group Limited - Class A Ordinary Shares
NASDAQ · Health Care · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Mar 31, 2026
$0.13
· of 52w range
· above low
· to high
$0.0652w low
$1539.0052w high
Market Cap
$31.0K
P/E
0.0
EPS
$3.04
Revenue
$5M
your badges
52W Range
$0–$1539
Analyst Rating
·
Price Target
$127
P/E
0.0
ROE
77.2%
Net Profit Margin
209.0%
Your badge strip is empty — pin a metric anywhere on this page.
NIVF Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.13
Market Cap
$31.0K
P/E
0.0
EPS
$3.04
Revenue
$5M
ROE
77.2%
52W Range
$0–$1539
NIVF Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| Sept. 1, 2026 | 1-for-3 | Reverse |
| July 6, 2026 | 1-for-3 | Reverse |
| March 16, 2026 | 1-for-4 | Reverse |
| Jan. 26, 2026 | 1-for-3 | Reverse |
| Dec. 3, 2025 | 1-for-5 | Reverse |
| Dec. 1, 2025 | 1-for-5 | Reverse |
| Aug. 4, 2025 | 1-for-5 | Reverse |
| May 5, 2025 | 1-for-10 | Reverse |
| Feb. 11, 2025 | 1-for-20 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$5M2021-12-31 → 2025-12-31
EPS$3.042021-12-31 → 2025-12-31
Free Cash Flow$-11M2023-12-31 → 2025-12-31
Net margin209.0%2023-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | NIVF | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | 0.05Y avg ≈0.1 | ≈0.1 | · | · | |
| P/S | 0.05Y avg ≈26.1 | ≈26.1 | · | · | |
| P/B | 0.05Y avg ≈134.2 | ≈134.2 | · | · | |
| Price / FCF | -0.05Y avg ≈-70.0 | ≈-70.0 | · | · | |
| Price / Cash Flow | -0.05Y avg ≈-72.7 | ≈-72.7 | · | · | |
| Price / Tangible Book | 0.0 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | NIVF | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin | 20.2%5Y avg ≈28.9% | ≈28.9% | · | · | |
| Operating Margin | -226.9%5Y avg ≈-82.5% | ≈-82.5% | · | · | |
| EBITDA Margin | -223.0%5Y avg ≈-80.8% | ≈-80.8% | · | · | |
| Pretax Margin | 205.8%5Y avg ≈63.4% | ≈63.4% | · | · | |
| Net Profit Margin | 209.0%5Y avg ≈67.3% | ≈67.3% | · | · | |
| ROA | 54.4%5Y avg ≈15.7% | ≈15.7% | · | · | |
| ROE | 77.2%5Y avg ≈18.7% | ≈18.7% | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | NIVF | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio | 3.15Y avg ≈1.8 | ≈1.8 | · | · | |
| Quick Ratio | 0.45Y avg ≈0.2 | ≈0.2 | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | NIVF | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.35Y avg ≈1.3 | ≈1.3 | · | · | |
| Inventory Turnover | 18.15Y avg ≈30.9 | ≈30.9 | · | · | |
| Receivables Turnover | 43.85Y avg ≈229.4 | ≈229.4 | · | · | |
| Revenue / Employee | ≈$54.3K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $5M | $5M | $5M | $6M | |
| Cost of Revenue | $4M | $4M | $3M | $4M | |
| Gross Profit | $955.8K | $2M | $2M | $2M | |
| SG&A Expense | $10M | $3M | $2M | $1M | |
| Operating Expenses | $12M | $3M | $2M | $1M | |
| Operating Income | $-11M | $-1M | $42.2K | $398.7K | |
| Interest Expense | · | $765.2K | · | · | |
| Interest Income | $2.3K | $7.0K | $518 | $21 | |
| Other Non-op | $20M | $199.7K | $66.2K | $-54.7K | |
| Pretax Income | $10M | $-960.8K | $108.4K | $344.0K | |
| Income Tax | · | $-486.7K | · | $208.1K | |
| Net Income | $10M | $-524.6K | $130.2K | $458.7K | |
| EPS (Basic) | $214.73 | $-4408.76 | $13019.30 | $4.72 | |
| EPS (Diluted) | $3.04 | $-4408.76 | $13019.30 | $4.72 | |
| Shares (Basic) | 46,009 | 119 | 10 | 28,797 | |
| Shares (Diluted) | 3,250,020 | 119 | 10 | 28,797 | |
| EBITDA | $-11M | $-1M | $73.4K | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $758.6K | $457.7K | $54.1K | $27.6K | |
| Receivables | $166.5K | $49.2K | $9.4K | $13.0K | |
| Inventory | $335.4K | $80.8K | $126.3K | $46.9K | |
| Prepaid Expense | $503.6K | $393.2K | $512.6K | $70.3K | |
| Current Assets | $7M | $3M | $2M | $2M | |
| PP&E (Net) | $2M | $273.1K | $162.2K | $122.7K | |
| PP&E (Gross) | $3M | $2M | $1M | $1M | |
| Accum. Depreciation | $1M | $1M | $1M | $1M | |
| Intangibles | $21M | · | · | · | |
| Total Assets | $33M | $4M | $4M | $3M | |
| Accounts Payable | $779.3K | $1M | $172.6K | $104.7K | |
| Accrued Liabilities | $514.2K | $201.5K | $43.6K | · | |
| Current Liabilities | $2M | $3M | $1M | $3M | |
| Capital Leases | $272.4K | $10.2K | $119.0K | $242.2K | |
| Total Liabilities | $7M | $5M | $1M | $3M | |
| Common Stock | · | · | · | $6.0K | |
| Paid-in Capital | $18M | $122.5K | $4M | $1M | |
| Retained Earnings | $9M | $-986.0K | $-461.4K | $-591.5K | |
| AOCI | $-143.1K | $18.9K | $-7.3K | $9.6K | |
| Stockholders' Equity | $27M | $-1M | $4M | $563.1K | |
| Liabilities + Equity | $33M | $4M | $4M | $3M | |
| Shares Outstanding | 240,622 | 380 | 169 | 167 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| D&A | $188.1K | $19.5K | $31.2K | $100.5K | |
| Stock-based Comp | · | · | · | $240.0K | |
| Other Non-cash | $-21M | $-8M | $-2M | · | |
| Operating Cash Flow | $-11M | $-8M | $-2M | $2M | |
| CapEx | $135.0K | $53.0K | $69.8K | $94.5K | |
| Investing Cash Flow | $-8M | $-53.0K | $-69.8K | $-94.5K | |
| Stock Issued | $13M | · | $192.3K | · | |
| Net Stock Activity | $13M | · | $192.3K | · | |
| Financing Cash Flow | $19M | $9M | $2M | $-2M | |
| Free Cash Flow | $-11M | $-8M | $-2M | · | |
| Levered FCF | · | $-9M | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Gross Margin | 20.2% | 33.6% | 32.7% | · | |
| Operating Margin | -226.9% | -21.4% | 0.82% | · | |
| Net Margin | 209.0% | -9.7% | 2.5% | · | |
| Pretax Margin | 205.8% | -17.7% | 2.1% | · | |
| EBITDA Margin | -223.0% | -21.0% | 1.4% | · | |
| ROA | 54.4% | -13.0% | 5.7% | · | |
| ROE | 77.2% | -39.1% | 17.8% | · | |
| ROIC | · | 54.6% | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 3.1 | 1.2 | 1.1 | · | |
| Quick Ratio | 0.4 | 0.2 | 0.1 | · | |
| Interest Coverage | · | -1.5 | · | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 1.3 | 2.3 | · | |
| Inventory Turnover | 18.1 | 34.8 | 39.9 | · | |
| Receivables Turnover | 43.8 | 185.4 | 459.1 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Book Value / Share | $110.68 | $-0.92 | $1.28 | · | |
| Revenue / Share | $1.45 | $7.31 | $8.35 | · | |
| Cash Flow / Share | $-3.36 | $-11.12 | $-2.87 | · | |
| Cash / Share | $3.15 | $0.40 | $0.08 | · | |
| EPS (TTM) | $3.04 | $-4408.76 | $13019.30 | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $5M | $5M | $5M | · | |
| Net Income TTM | $10M | $-524.6K | $130.2K | · | |
| Market Cap | $166.0K | $23M | $380M | · | |
| P/E | 0.2 | -0.0 | 0.0 | · | |
| P/S | 0.0 | 4.2 | 74.1 | · | |
| P/B | 0.0 | -22.0 | 424.6 | · | |
| P / Tangible Book | 0.0 | · | 101.9 | · | |
| P / Cash Flow | -0.0 | -2.8 | -215.4 | · | |
| P / FCF | -0.0 | -2.8 | -207.2 | · | |
| Earnings Yield | 440.6% | -21771.7% | 2388.9% | · |
Per Share
| Metric | Trend | Q4 2025 | Q4 2024 |
|---|---|---|---|
| EPS (TTM) | $3.04 | · |
Valuation (TTM)
| Metric | Trend | Q4 2025 | Q4 2024 |
|---|---|---|---|
| Revenue TTM | $5M | · | |
| Net Income TTM | $10M | · | |
| P/E | 24.5 | · | |
| Earnings Yield | 4.1% | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $5M | $5M | $5M | $6M | $4M |
| Gross Margin % | 20.2% | 33.6% | 32.7% | · | · |
| Operating Margin % | -226.9% | -21.4% | 0.82% | · | · |
| Net Income | $10M | $-524.6K | $130.2K | $458.7K | $-533 |
| Diluted EPS | $3.04 | $-4408.76 | $13019.30 | $4.72 | $0.00 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 3.1 | 1.2 | 1.1 | · | · |
| Quick Ratio | 0.4 | 0.2 | 0.1 | · | · |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-11M | $-8M | $-2M | · | · |
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Wing Fung Alfred Siu, Hei Yue Tina Fong ×2 filings | June 8, 2026 | 2.80% | Amendment | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 3 insiders · 0 officers · 2 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Wing Fung Alfred Siu | Director | June 4, 2026 M | 56,881 | 0 | 0 | $0 |
| Hei Yue Tina Fong | Director | June 4, 2026 M | 56,890 | 0 | 0 | $0 |
| HRT FINANCIAL LP | 10% owner | June 4, 2026 S | 18,134 | 4 | 2 | $74,975 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
NIVF Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
12-Month Price Target
1 analysts · 2026-10-02Mean target $127.08 +98411.6%
Low$127.08
Mean$127.08
High$127.08
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 20-F filed Mar 31, 2026